See https://diversity.ucdavis.edu/news/new-leaders-diversity-equity-and-inclusion for the full article
The Office for Diversity, Equity and Inclusion is delighted to announce the appointment of Luis Carvajal-Carmona, Ph.D., as Associate Vice Chancellor for the Office of Academic Diversity (DEI/OAD), effective March 1, 2023.
The Associate Vice Chancellor for the Office of Academic Diversity plays an influential role in the DEI office as we seek to empower faculty equity leaders, elevate the work of diverse faculty as they solve global problems, support equitable ecosystems for student opportunity through our HSI initiative, and model equity inclusion in higher education.
Luis’ position reports directly to Renetta G. Tull, Vice Chancellor for Diversity, Equity, and Inclusion, and will serve on her core leadership team. “I am thrilled and excited to have these two talented leaders on our team who are experts and already contributing to advancing our DEI goals,” Tull said.
Dr. Carvajal-Carmona is professor of Biochemistry and Molecular Medicine and holds the Auburn Community Cancer Endowed Chair in Basic Science in the University of California Davis (UCD). He is the Associate Director for the Inclusivity, Diversity, Equity and Accessibility (IDEAL) Office, and the Founder Director of the Latinos United for Cancer Health Advancement (LUCHA) Initiative and of the Center for Advancing Cancer Health Equity at the UCD Comprehensive Cancer Center. At the UCD Clinical and Translation Science Center, he co-directs of the Community Engagement Program.
“As a nationally recognized scientist and workforce diversity advocate, I look forward to working with VC Tull, our amazing DEI office team and our great leaders at Mrak Hall to advance inclusive excellence and to promote all dimensions of diversity among our students and faculty,” Carvajal-Carmona said.
As a researcher, Professor Carvajal-Carmona specializes on cancer genetics, epidemiology, health disparities and global health. His main contributions to science include the elucidation of the genetic origins of Latino populations, the discovery of the first common variants increasing risk of colorectal cancer and the identification of a novel familial form of gastric cancer. He has discovered multiple cancer susceptibility genes and variants and has published over 100 manuscripts in influential journals such as Nature Genetics, Gastroenterology, American Journal of Human Genetics, Lancet Gastroenterology and Hepatology and PNAS. He has received awards and fellowships from the European Association for Cancer Research, The University of Oxford and the V Foundation. Carvajal-Carmona has received funding from multiple agencies in Europe (Cancer Research UK, European Union, GSK Oncology) and the U.S. (V Foundation, California Initiative to Advance Precision Medicine, NIH) and is currently PI/MPI of grants totaling >$17M in research funding.
In addition to his passionate pursuit for scientific research, Carvajal-Carmona is a keen supporter of a diverse biomedical research force. He has mentored dozens of undergraduate and graduate students, 95% of whom have been first-generation college graduates and members of under-represented groups. His mentees have been awarded 50+ fellowships and research awards and are all currently pursuing higher education or are employed at leading institutions and companies. In addition to the satisfaction of helping people with his research, Carvajal-Carmona’s most rewarding accomplishment is to see his mentees shine and achieve their dreams. He has been awarded the UCD Chancellor’s Award for Excellence in Mentoring Undergraduate Research and the UCD ADVANCE Scholar Award for his outstanding scholarship and mentorship.
